Inactivated canine coronavirus vaccine

Details Inactivated canine coronavirus vaccine Inactivated canine coronavirus vaccine

1984-06-07

1986-01-28

Marantz, Sidney

Drug, bio-affecting and body treating compositions

Lymphokine

A61K 3912

Patent

active

045670420

ABSTRACT:
An efficacious parenterally administered inactivated canine coronavirus vaccine which provides systemic, humoral protection and also protection of the intestinal tract in dogs from infection by virulent canine coronavirus is produced. A method for propagation of the canine coronavirus and its attenuation and a method of evaluating the effectiveness of a canine coronavirus vaccine in canines is also disclosed.

REFERENCES:
Gill, Michael A., Isolation and Characterization of a Canine Coronavirus, Ph.D Thesis, University of Nebraska-Lincoln, 1982.
Pollock et al., Vet. Clin. North Am., Aug. 1983, 13(3) pp. 551-566.
Appel et al., Canine Practice, vol. 7, No. 4, pp. 22-34 (1980).

Affiliated with

Also associated with

Rating

Inactivated canine coronavirus vaccine does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Inactivated canine coronavirus vaccine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inactivated canine coronavirus vaccine will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1305643